Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Remyelination”

37 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 37 results

Testing effectiveness (Phase 2)Study completedNCT05131828
What this trial is testing

CCMR Two: A Phase IIa, Randomised, Double-blind, Placebo-controlled Trial of the Ability of the Combination of Metformin and Clemastine to Promote Remyelination in People With Relapsing-remitting Multiple Sclerosis Already on Disease-modifying Therapy

Who this might be right for
Multiple Sclerosis
Cambridge University Hospitals NHS Foundation Trust 70
Early research (Phase 1)Study completedNCT02760056
What this trial is testing

Thyroid Hormone for Remyelination in Multiple Sclerosis (MS): A Safety and Dose Finding Study

Who this might be right for
Multiple Sclerosis
Oregon Health and Science University 15
Not applicableUnknownNCT05147532
What this trial is testing

Remyelination in Multiple Sclerosis: a PET-MR Longitudinal Study Investigating Individual Profiles of Myelin Repair and the Contribution of Neuroinflammation

Who this might be right for
Multiple SclerosisInflammatory Disease
Assistance Publique - Hôpitaux de Paris 80
Not applicableNot Yet RecruitingNCT07723599
What this trial is testing

Combating Age-related Failure of Myelination in Multiple Sclerosis: An Exploratory Study

Who this might be right for
Multiple Sclerosis
University of Washington 14
Large-scale testing (Phase 3)Study completedNCT01307332
What this trial is testing

Advanced MRI Measures of Repair in Alemtuzumab Treated Patients

Who this might be right for
Relapsing Remitting Multiple Sclerosis
University of British Columbia 27
Testing effectiveness (Phase 2)Looking for participantsNCT07304024
What this trial is testing

A Treatment for a Form of Age-Related Central Auditory Processing Disorder Consisting of Clemastine Fumarate Plus Engineered Sound

Who this might be right for
Central Auditory Processing DisorderHearing Impaired (Partially)Hearing+23 more
University of Colorado, Denver 344
Large-scale testing (Phase 3)Study completedNCT04626921
What this trial is testing

A Multi-Center, Open-Label Long-Term Extension Study of CNM-Au8 In Patients With Stable Relapsing Multiple Sclerosis

Who this might be right for
Relapsing Multiple Sclerosis
Clene Nanomedicine 55
Testing effectiveness (Phase 2)Ended earlyNCT01037907
What this trial is testing

Orally Administered BGC20-0134 (Structured Lipid) in Patients With Relapsing Remitting Multiple Sclerosis (RRMS)

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Boston Scientific Corporation 173
Testing effectiveness (Phase 2)Study completedNCT02087631
What this trial is testing

Safety and Tolerability of Quetiapine in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
University of Calgary 14
Large-scale testing (Phase 3)Ended earlyNCT05338450
What this trial is testing

Clemastine Fumarate as Remyelinating Treatment in Internuclear Ophthalmoparesis and Multiple Sclerosis

Who this might be right for
Multiple SclerosisInternuclear Ophthalmoplegia
Amsterdam UMC, location VUmc 47
Testing effectiveness (Phase 2)Study completedNCT04002934
What this trial is testing

Bazedoxifene Acetate as a Remyelinating Agent in Multiple Sclerosis

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-Remitting
Riley Bove, MD 63
Not applicableEnrolling By InvitationNCT06641271
What this trial is testing

Study to Investigate Vagus Nerve Stimulation Paired With Motor Task for Remyelination and Functional Recovery

Who this might be right for
Multiple Sclerosis (MS) - Relapsing-remittingMultiple Sclerosis
University of Colorado, Denver 70
Large-scale testing (Phase 3)Study completedNCT03774407
What this trial is testing

Vaginal Estriol in Multiple Sclerosis

Who this might be right for
Multiple SclerosisNeurogenic Bladder
Texas Tech University Health Sciences Center 21
Testing effectiveness (Phase 2)Looking for participantsNCT03910738
What this trial is testing

TOTEM RRMS : TestOsterone TreatmEnt on Neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
University Hospital, Strasbourg, France 40
Early research (Phase 1)Ended earlyNCT06617546
What this trial is testing

SAD and MAD Study of FTX-101 in Healthy Male Subjects

Who this might be right for
Healthy Volunteers
Find Therapeutics 49
Testing effectiveness (Phase 2)Study completedNCT04539002
What this trial is testing

Aerobic Exercise for Remyelination in Multiple Sclerosis

Who this might be right for
Multiple SclerosisSclerosisDemyelinating Diseases+4 more
Oregon Health and Science University 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07826689
What this trial is testing

A Phase 1/2a Study of Oral PRO-1562 in Healthy Subjects and Patients With Relapsing Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Progentos Therapeutics 160
Testing effectiveness (Phase 2)WithdrawnNCT00986960
What this trial is testing

Effect of Adrenocorticotropin Injection With Weekly Interferon Beta in Patients With Relapsing Remitting Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis
University at Buffalo
Testing effectiveness (Phase 2)Active Not RecruitingNCT05893225
What this trial is testing

Metformin Add-on Clinical Study in Multiple Sclerosis to Evaluate Brain Remyelination And Neurodegeneration

Who this might be right for
Multiple SclerosisPrimary Progressive Multiple SclerosisSecondary-progressive Multiple Sclerosis
University Hospital, Antwerp 120
Testing effectiveness (Phase 2)Study completedNCT02493049
What this trial is testing

Pilot Trial of Domperidone in Relapsing-Remitting Multiple Sclerosis (RRMS)

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
University of Calgary 17
Next Page